summARY The actuarial survival and thromboembolic rates for the three types of cloth-covered StarrEdwards mitral prostheses, models 6300, 6310/6320, and 6400 followed 6, 5, and 2 years, respectively, were not significantly different throughout the years they were followed. The combined cumulative survival and thromboembolic proportion at 5 years for these prostheses were 71 and 66 per cent, respectively. The thromboembolic rates were not different in the following two groups: (a) 238 patients receiving anticoagulants, and (b) 52 patients who had discontinued or who were not receiving anticoagulants.
The incidence of complications, particularly throm-assessed while receiving therapy with both digitalis boembolism, has significantly decreased since the and diuretics. Anticoagulant therapy with warfarin introduction of cloth covering of the Starr-Edwards was prescribed in all patients starting on the third mitral prostheses (Bonchek and Starr, 1975) . postoperative day and continued for one month. Model 6300 is the earliest model in which both ring It was discontinued in patients where the distance and cage were 'teflon' covered. In the 'composite they had to travel made it impractical, while specific seat' prostheses, models 6310 and 6320, studs were contraindications were present, or where patients added to the inner ring to prevent wear of the seat were unreliable. Warfarin therapy was prescribed covering by the ball. The current 'track valve', with the object of maintaining the prothrombin model 6400, has a metal inner aspect of the poly-time between 11 and 2j times control. Quick propylene covered struts to prevent sticking of the prothrombin time was measured using local human ball (Bonchek et al., 1974 6310/b320
of whom were not receiving anticoagulants.
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Sixteen patients who had class 3 or 4 symptoms o postoperatively were subjected to routine right and left heart haemodynamic studies to determine the ' cause of their disability. Ejection fraction was $ 40 measured by the method of Sandler and Dodge (1968) and end-diastolic volume was calculated by dividing cardiac output by the product of heart rate and ejection fraction in the absence of aortic or 20 mitral regurgitation. Years after operation Early Fig. 1 Actuarial survival curvesfor three models of The operative and hospital mortality or the mor-cloth-covered Starr-Edwards prostheses. There was no tality withi 30 days of operation for all patients significant difference in interval survival proportions was 8 per cent: 11 per cent for model 6300, 9 per between each model at each year after operation cent for model 6310/6320, and 6 per cent for model (P>0-1) (vertical bars denote SE). 6400 prostheses. In no instance did death result from primary prosthetic valve malfunction.
Late
and 10 recovered completely after hospital admisThirty-nine late deaths were recorded. Necropsies sion. Four additional patients developed valvar were performed in 20, including 4 patients who, thrombosis, and in 2 it was associated with major despite receiving anticoagulants, died of valvar cerebral amboli. Actuarial analysis of thrombothrombosis. The commonest cause of death was embolic-free events in patients with each type thromboembolism which was recorded in 15 patients. prosthesis is shown in Fig. 2 . Only the first occurTwo of these patients were not receiving anticoagu-rence of an event was considered in the analysis lants. Nine patients died suddenly and unex- (Anderson et al., 1974) . There was no significant pectedly. It is possible that some of these patients difference in thromboembolic-free cumulative prohad malignant arrhythmias or thromboembolism. portion for each type of prosthesis at each yearly Actuarial analysis of survival, which includes interval (P >0.1), i.e. for 2 years of follow-up of operative deaths, for each type of prosthesis is shown model 6400 and 5 years of models 6300 and 6310/ in Fig. 1 . The 5-year survival of the 332 patients, 82 6320. The 5 year cumulative thromboembolic-free of whom were in or had completed their fifth year proportion for the combined data of the 3 models of follow-up, was 71 per cent. There was no signi-was 66 per cent. ficant difference in survival proportions for each
To determine the effect of anticoagulant therapy model prosthesis at each yearly interval (P >0.1), after discharge from hospital the data from 3 i.e. for 2 years of follow-up of model 6400 and 5 models were pooled and divided into 2 groups:
years of models 6300 (1973) have described extensive endocardial fibrosis seen at The actuarial survival and thromboembolic rates necropsy in patients with Starr-Edwards mitral for the three types of cloth-covered Starr-Edwards prostheses which they attributed to altered flow mitral prosthetic valves, models 6300, 6310/6320, patterns around the caged ball. This pathology may and 6400 were not significantly different. This is in account for the restrictive left ventricular disease contrast to the results of Starr, who found a dif-seen in 4 of our patients. In contrast the myopathy ference in survival and thromboembolism between seen in patients with mitral prostheses has been well models 6300 and 6310/6320 (Kirklin and Pacifico, documented (Peterson et al., 1967; Hildner et al., 1973) . The longest follow-up of patients with 1972) and has been variously attributed to rheumodel 6400 is at present in the third year and our matic involvement, chronic volume overload, assessment of this prosthesis is, therefore, pre-intraoperative damage, and postoperative microliminary. We postulate that it will not be different emboli. from the other models when followed over 5 years. The thromboembolic incidence for models 6300 and 6310/6320 is higher than that reported by References Starr's group (Bonchek and Starr, 1975) (Anderson et al., 1974) Aris, A., Fast, A. J., Tector, A. J., Flemma, R. J., and Lepley, D. (1974 (Katholi et al., 1976) in the majority of those patients and Cardiovascular Surgery, 67, 93-109. who had thromboembolic complications. It is Bonchek, L. I., and Starr, A. (1975). Ball valve prostheses: possible that the prothrombin time should be con- (Bonchek and Starr, 1975) and then diminished 288, [194] [195] [196] [197] [198] [199] . rapidly. This was not our experience as we found Peterson, C. R., Herr, R., Crisera, R. V., Starr, A., Bristow, J. D., and Griswold, H. E. (1967) . The failure of hemodythe incidence did not decrease over 5 years of namic improvement after valve replacement surgery. follow-up.
Annals of Internal Medicine, 66, 1-24. We have not objectively tested exercise capabili-Roberts, W. C., Bulkley, B. H., and Morrow, A. G. (1973) . ties of our patients postoperatively but have relied Pathologic anatomy of cardiac valve replacement: a study of 224 necropsy patients. Progress in Cardiovascular Diseases, on their subjective symptoms to assess their effort 15, 539-587. tolerance. This can be notoriously unreliable Sandlier, H., and Dodge, H. T. (1968) . The use of single plane (Selzer and Cohn, 1972) 
